Showing results (171-180 of 340) with videos related to
Sort By:
Pageof 34
Transplantation and Cellular Therapy|November 28, 2022
Expanded HCT-CI Definitions Capture Comorbidity Better for Younger Patients of Allogeneic HCT for Nonmalignant DiseasesLarisa Broglie, Brian D Friend, Saurabh Chhabra, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 22, 2013
Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant researchMehdi Hamadani, Wael Saber, Kwang Woo Ahn, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2020
Baseline Gut Microbiota Composition Is Associated with Major Infections Early after Hematopoietic Cell TransplantationHemant S Murthy, Raad Z Gharaibeh, Zeina Al-Mansour, et al.Diabetes Care|October 21, 2011
Autologous umbilical cord blood transfusion in young children with type 1 diabetes fails to preserve C-peptideMichael J Haller, Clive H Wasserfall, Maigan A Hulme, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 28, 2020
Dietary Intake and Diet Quality of Hematopoietic Stem Cell Transplantation SurvivorsNosha Farhadfar, Debra L Kelly, Lacey Mead, et al.Medicine|July 10, 2010
Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysisAmar Safdar, Jonathan Ma, Fouzi Saliba, et al.Journal of Clinical Microbiology|April 11, 2014
Long-term stability at -20 °C of Aspergillus galactomannan in serum and bronchoalveolar lavage specimensL Joseph Wheat, M Hong Nguyen, Barbara D Alexander, et al.Leukemia & Lymphoma|August 15, 2003
A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial)Francis J Giles, Carole B Miller, David D Hurd, et al.Blood|May 16, 2009
Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials NetworkAmin M Alousi, Daniel J Weisdorf, Brent R Logan, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 19, 2012
First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow TransplantationPaul J Martin, J Douglas Rizzo, John R Wingard, et al.Pageof 34